Aspire Biopharma, Inc. reports a Return on Equity (ROE) of -304.06%.

What is ASBP's dividend yield?

Aspire Biopharma, Inc. offers a dividend yield of 0.00%.

What is ASBP's Quality Score?

Our AI rates ASBP's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ASBP?

Our AI Timing Score for ASBP is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ASBP belong to?

Aspire Biopharma, Inc. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

Aspire Biopharma, Inc. (ASBP) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-06 | FS: 2026-03-31)

ASBP AI Analysis Summary

Our AI summary for ASBP: Aspire Biopharma, Inc. (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -304.06%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ASBP

Aspire Biopharma, Inc.

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 7.06

-0.20 (-2.75%) Day Change

Watchlist Portfolio Compare Chart

0.39

D/E

-304.1%

ROE

-165.3%

ROA

0.00%

Div Yield

ASPIRE BIOPHARMA, INC.
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 7.06 Price -0.20 (-2.75%) Day Change	NEWS SCORE: 91

ASBP, the overall quality is not good ( Quality = 38) but the timing to buy is ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Negative growth of ROE in the last year.
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	7.06
PBV / Sector	2.43 / 5.21
Earning Per Share	-8.83

PE / Sector	N/A / 21.00
PEG or PE/Growth / Sector	N/A / 1.11
Average 1M Daily Value	0.32 M GREAT
Average 1W Daily Value	0.16 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-34,039.68 / 95.56
NPM Average (%) / Sector	-214,382.37 / -1,676.77
NPM Change Average (%) / Sector	N/A / 4,917.73
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-165.27 / 25.44
ROA Average (%) / Sector	-2,095.81 / -350.66
ROA Change Average (%) / Sector	-9,070.75 / 5,110.09
ROE (%) / Sector	-304.06 / 3.07
ROE Average (%) / Sector	183.57 / 4.81 GREAT
ROE Change Average (%) / Sector	1,277.90 / 2,068.02
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.02
Dividend Average (%) / Sector	N/A / 17.10
Dividend Change Average (%) / Sector	N/A / 0.98

Registration Details

Analyze Date	2026-08-07 08:11:19
Symbol	ASBP
Name	ASPIRE BIOPHARMA, INC.
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	1.30 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	9.40 / 9,672.56

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 23150 Fashion Drive, Estero, FL, United States, 33928

Phone: 908 987 3002

Website: https://aspirebiolabs.com

Sector: Healthcare >> Biotechnology

Description: Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.